{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T06:18:00Z","timestamp":1775283480691,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,3]]},"DOI":"10.7759\/cureus.106412","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T05:41:36Z","timestamp":1775281296000},"source":"Crossref","is-referenced-by-count":0,"title":["Association Between Liver Dysfunction Markers and Mortality in Heart Failure: A Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Ali","family":"Salman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Irshad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamza I","family":"Chughtai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Arslan","family":"Riaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.15420\/cfr.2023.05","article-title":"Global public health burden of heart failure: an updated review","volume":"9","author":"Shahim B","year":"2023","unstructured":"Shahim B, Kapelios CJ, Savarese G, Lund LH. Global public health burden of heart failure: an updated review. Card Fail Rev. 2023, 9:11. 10.15420\/cfr.2023.05","journal-title":"Card Fail Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2022-321702","article-title":"Prevalence, outcomes and costs of a contemporary, multinational population with heart failure","volume":"109","author":"Norhammar A","year":"2023","unstructured":"Norhammar A, Bodegard J, Vanderheyden M, et al.. Prevalence, outcomes and costs of a contemporary, multinational population with heart failure. Heart. 2023, 109:548-56. 10.1136\/heartjnl-2022-321702","journal-title":"Heart"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd12030104","article-title":"Transition to advanced heart failure: from identification to improving prognosis","volume":"12","author":"Tepetes NI","year":"2025","unstructured":"Tepetes NI, Kourek C, Papamichail A, Xanthopoulos A, Kostakou P, Paraskevaidis I, Briasoulis A. Transition to advanced heart failure: from identification to improving prognosis. J Cardiovasc Dev Dis. 2025, 12:104. 10.3390\/jcdd12030104","journal-title":"J Cardiovasc Dev Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd12040124","article-title":"Unveiling the systemic impact of congestion in heart failure: a narrative review of multisystem pathophysiology and clinical implications","volume":"12","author":"Mocan D","year":"2025","unstructured":"Mocan D, Jipa R, Jipa DA, et al.. Unveiling the systemic impact of congestion in heart failure: a narrative review of multisystem pathophysiology and clinical implications. J Cardiovasc Dev Dis. 2025, 12:124. 10.3390\/jcdd12040124","journal-title":"J Cardiovasc Dev Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1932","article-title":"Looking at the heart failure through the prism of liver dysfunction","volume":"22","author":"Zymli\u0144ski R","year":"2020","unstructured":"Zymli\u0144ski R, Ponikowski P, Biegus J. Looking at the heart failure through the prism of liver dysfunction. Eur J Heart Fail. 2020, 22:1672-4. 10.1002\/ejhf.1932","journal-title":"Eur J Heart Fail"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2021.100249","article-title":"From congestive hepatopathy to hepatocellular carcinoma, how can we improve patient management?","volume":"3","author":"Sessa A","year":"2021","unstructured":"Sessa A, Allaire M, Lebray P, Medmoun M, Tiritilli A, Iaria P, Cadranel JF. From congestive hepatopathy to hepatocellular carcinoma, how can we improve patient management?. JHEP Rep. 2021, 3:100249. 10.1016\/j.jhepr.2021.100249","journal-title":"JHEP Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5152\/tjg.2015.0086","article-title":"How to interpret liver function tests in heart failure patients?","volume":"26","author":"\u00c7a\u011fl\u0131 K","year":"2015","unstructured":"\u00c7a\u011fl\u0131 K, Ba\u015far FN, Tok D, Turak O, Ba\u015far \u00d6. How to interpret liver function tests in heart failure patients?. Turk J Gastroenterol. 2015, 26:197-203. 10.5152\/tjg.2015.0086","journal-title":"Turk J Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11121241","article-title":"The cardio-hepatic relation in STEMI","volume":"11","author":"Bannon L","year":"2021","unstructured":"Bannon L, Merdler I, Bar N, Lupu L, Banai S, Jacob G, Shacham Y. The cardio-hepatic relation in STEMI. J Pers Med. 2021, 11:1241. 10.3390\/jpm11121241","journal-title":"J Pers Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-021-01941-7","article-title":"Prognostic value of the modified Model for End-Stage Liver Disease (MELD) score including albumin in acute heart failure","volume":"21","author":"Liao S","year":"2021","unstructured":"Liao S, Lu X, Cheang I, et al.. Prognostic value of the modified Model for End-Stage Liver Disease (MELD) score including albumin in acute heart failure. BMC Cardiovasc Disord. 2021, 21:128. 10.1186\/s12872-021-01941-7","journal-title":"BMC Cardiovasc Disord"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2015.10.008","article-title":"Model for End-Stage Liver Disease excluding international normalized ratio (MELD-XI) score predicts heart transplant outcomes: evidence from the registry of the United Network for Organ Sharing","volume":"35","author":"Deo SV","year":"2016","unstructured":"Deo SV, Al-Kindi SG, Altarabsheh SE, et al.. Model for End-Stage Liver Disease excluding international normalized ratio (MELD-XI) score predicts heart transplant outcomes: evidence from the registry of the United Network for Organ Sharing. J Heart Lung Transplant. 2016, 35:222-7. 10.1016\/j.healun.2015.10.008","journal-title":"J Heart Lung Transplant"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.39267","article-title":"Model for End Stage Liver Disease (MELD) score: a tool for prognosis and prediction of mortality in patients with decompensated liver cirrhosis","volume":"15","author":"Emenena I","year":"2023","unstructured":"Emenena I, Emenena B, Kweki AG, et al.. Model for End Stage Liver Disease (MELD) score: a tool for prognosis and prediction of mortality in patients with decompensated liver cirrhosis. Cureus. 2023, 15:39267. 10.7759\/cureus.39267","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.13776","article-title":"Prognostic value of the MELD-XI score in patients undergoing cardiac resynchronization therapy","volume":"9","author":"Saito Y","year":"2022","unstructured":"Saito Y, Nakai T, Ikeya Y, et al.. Prognostic value of the MELD-XI score in patients undergoing cardiac resynchronization therapy. ESC Heart Fail. 2022, 9:1080-9. 10.1002\/ehf2.13776","journal-title":"ESC Heart Fail"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.15002","article-title":"MELD score predicts outcomes in patients with advanced heart failure: a longitudinal evaluation","volume":"12","author":"Curcio F","year":"2025","unstructured":"Curcio F, Amarelli C, Chiappetti R, et al.. MELD score predicts outcomes in patients with advanced heart failure: a longitudinal evaluation. ESC Heart Fail. 2025, 12:839-47. 10.1002\/ehf2.15002","journal-title":"ESC Heart Fail"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.13195","article-title":"Prognostic value of impaired hepato-renal function and liver fibrosis in patients admitted for acute heart failure","volume":"8","author":"Kawahira M","year":"2021","unstructured":"Kawahira M, Tamaki S, Yamada T, et al.. Prognostic value of impaired hepato-renal function and liver fibrosis in patients admitted for acute heart failure. ESC Heart Fail. 2021, 8:1274-83. 10.1002\/ehf2.13195","journal-title":"ESC Heart Fail"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s43162-025-00533-7","article-title":"Liver dysfunction indices as a predictor for in-hospital mortality in acute heart failure patients","volume":"37","author":"Ali SM","year":"2025","unstructured":"Ali SM, Saad AM, Mohamed RA-E, Mohamed MF, Shennawy AM. Liver dysfunction indices as a predictor for in-hospital mortality in acute heart failure patients. Egypt J Intern Med. 2025, 37:150. 10.1186\/s43162-025-00533-7","journal-title":"Egypt J Intern Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-025-04647-2","article-title":"Liver biomarkers as predictors of prognosis in heart failure with preserved ejection fraction: a systematic review and meta-analysis","volume":"25","author":"Dastjerdi P","year":"2025","unstructured":"Dastjerdi P, Mahalleh M, Shayesteh H, et al.. Liver biomarkers as predictors of prognosis in heart failure with preserved ejection fraction: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2025, 25:244. 10.1186\/s12872-025-04647-2","journal-title":"BMC Cardiovasc Disord"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.12.056","article-title":"Hepatic dysfunction in ambulatory patients with heart failure: application of the MELD scoring system for outcome prediction","volume":"61","author":"Kim MS","year":"2013","unstructured":"Kim MS, Kato TS, Farr M, et al.. Hepatic dysfunction in ambulatory patients with heart failure: application of the MELD scoring system for outcome prediction. J Am Coll Cardiol. 2013, 61:2253-61. 10.1016\/j.jacc.2012.12.056","journal-title":"J Am Coll Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13082000","article-title":"Model for End-Stage Liver Disease excluding INR is associated with poor prognosis in elderly patients with decompensated heart failure","volume":"13","author":"Jurkiewicz M","year":"2025","unstructured":"Jurkiewicz M, Szczurek-Wasilewicz W, Skrzypek M, J\u00f3\u017awiak JJ, G\u0105sior M, Szygu\u0142a-Jurkiewicz B. Model for End-Stage Liver Disease excluding INR is associated with poor prognosis in elderly patients with decompensated heart failure. Biomedicines. 2025, 13:2000. 10.3390\/biomedicines13082000","journal-title":"Biomedicines"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.14326","article-title":"Fibrosis-4 index identifies worsening renal function associated with adverse outcomes in acute heart failure","volume":"10","author":"Tsuda K","year":"2023","unstructured":"Tsuda K, Maeda D, Kanzaki Y, et al.. Fibrosis-4 index identifies worsening renal function associated with adverse outcomes in acute heart failure. ESC Heart Fail. 2023, 10:1726-34. 10.1002\/ehf2.14326","journal-title":"ESC Heart Fail"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref21","unstructured":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. (2026). Accessed. March 14, 2026: https:\/\/ohri.ca\/en\/who-we-are\/core-facilities-and-platforms\/ottawa-methods-centre\/newcastle-ottawa-scale."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.644","article-title":"Impaired hepato-renal function defined by the MELD XI score as prognosticator in acute heart failure","volume":"18","author":"Biegus J","year":"2016","unstructured":"Biegus J, Zymli\u0144ski R, Sokolski M, et al.. Impaired hepato-renal function defined by the MELD XI score as prognosticator in acute heart failure. Eur J Heart Fail. 2016, 18:1518-21. 10.1002\/ejhf.644","journal-title":"Eur J Heart Fail"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2019.12.003","article-title":"Clinical and prognostic values of ALBI score in patients with acute heart failure","volume":"29","author":"Matsue Y","year":"2020","unstructured":"Matsue Y, Kagiyama N, Yamaguchi T, et al.. Clinical and prognostic values of ALBI score in patients with acute heart failure. Heart Lung Circ. 2020, 29:1328-37. 10.1016\/j.hlc.2019.12.003","journal-title":"Heart Lung Circ"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.650191","article-title":"Mmmeld-XI score is associated with short-term adverse events in patients with heart failure with preserved ejection fraction","volume":"8","author":"Wang S","year":"2021","unstructured":"Wang S, Wang Y, Luo M, et al.. Mmmeld-XI score is associated with short-term adverse events in patients with heart failure with preserved ejection fraction. Front Cardiovasc Med. 2021, 8:650191. 10.3389\/fcvm.2021.650191","journal-title":"Front Cardiovasc Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.985503","article-title":"The MELD-XI score predicts 3-year mortality in patients with chronic heart failure","volume":"9","author":"Lin Z","year":"2022","unstructured":"Lin Z, Liu X, Xiao L, et al.. The MELD-XI score predicts 3-year mortality in patients with chronic heart failure. Front Cardiovasc Med. 2022, 9:985503. 10.3389\/fcvm.2022.985503","journal-title":"Front Cardiovasc Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242115665","article-title":"The liver in heart failure: from biomarkers to clinical risk","volume":"24","author":"Aspromonte N","year":"2023","unstructured":"Aspromonte N, Fumarulo I, Petrucci L, et al.. The liver in heart failure: from biomarkers to clinical risk. Int J Mol Sci. 2023, 24:15665. 10.3390\/ijms242115665","journal-title":"Int J Mol Sci"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.32756\/0869-5490-2021-1-70-74","article-title":"Prevalence and prognostic significance of liver damage in chronic heart failure (Article in Russian)","volume":"30","author":"Arisheva O","year":"2021","unstructured":"Arisheva O, Garmash I, Sarlykov B. Prevalence and prognostic significance of liver damage in chronic heart failure (Article in Russian). Clin Pharmacol Ther. 2021, 30:70-4. 10.32756\/0869-5490-2021-1-70-74","journal-title":"Clin Pharmacol Ther"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3390\/cells9030567","article-title":"Relationship between heart disease and liver disease: a two-way street","volume":"9","author":"El Hadi H","year":"2020","unstructured":"El Hadi H, Di Vincenzo A, Vettor R, Rossato M. Relationship between heart disease and liver disease: a two-way street. Cells. 2020, 9:567. 10.3390\/cells9030567","journal-title":"Cells"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.14046","article-title":"Prognostic importance of improving hepatorenal function during hospitalization in acute decompensated heart failure","volume":"9","author":"Mizobuchi S","year":"2022","unstructured":"Mizobuchi S, Saito Y, Fujito H, et al.. Prognostic importance of improving hepatorenal function during hospitalization in acute decompensated heart failure. ESC Heart Fail. 2022, 9:3113-23. 10.1002\/ehf2.14046","journal-title":"ESC Heart Fail"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.20996\/1819-6446-2024-3042","article-title":"Clinical and prognostic value of the MELD-XI score in hospitalized patients with chronic heart failure","volume":"20","author":"Dragomiretskaya NA","year":"2024","unstructured":"Dragomiretskaya NA, Podzolkov VI, Tolmacheva AV, Shvedov II, Vetluzhskaya MV, Chistyakova VD. Clinical and prognostic value of the MELD-XI score in hospitalized patients with chronic heart failure. Ration Pharmacother Cardiol. 2024, 20:174-82. 10.20996\/1819-6446-2024-3042","journal-title":"Ration Pharmacother Cardiol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.hroo.2024.12.014","article-title":"Prognostic value of the modified Model for End-Stage Liver Disease score in patients treated with cardiac resynchronization therapy","volume":"6","author":"Long T","year":"2025","unstructured":"Long T, Yu Y, Cheng S, Huang H, Hua W. Prognostic value of the modified Model for End-Stage Liver Disease score in patients treated with cardiac resynchronization therapy. Heart Rhythm O2. 2025, 6:339-49. 10.1016\/j.hroo.2024.12.014","journal-title":"Heart Rhythm O2"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1284434","article-title":"Liver abnormalities in cardiac diseases and heart failure","volume":"20","author":"Alvarez AM","year":"2011","unstructured":"Alvarez AM, Mukherjee D. Liver abnormalities in cardiac diseases and heart failure. Int J Angiol. 2011, 20:135-42. 10.1055\/s-0031-1284434","journal-title":"Int J Angiol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.2147\/HMER.S9049","article-title":"Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine","volume":"5","author":"Lau T","year":"2013","unstructured":"Lau T, Ahmad J. Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine. Hepat Med. 2013, 5:1-10. 10.2147\/HMER.S9049","journal-title":"Hepat Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1590\/0102-672020180001e1370","article-title":"The use of MELD score (Model for End-Stage Liver Disease) and derivatives in cardiac transplantation","volume":"31","author":"Moraes AC","year":"2018","unstructured":"Moraes AC, Fonseca-Neto OC. The use of MELD score (Model for End-Stage Liver Disease) and derivatives in cardiac transplantation. Arq Bras Cir Dig. 2018, 31:1370. 10.1590\/0102-672020180001e1370","journal-title":"Arq Bras Cir Dig"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/477075-association-between-liver-dysfunction-markers-and-mortality-in-heart-failure-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T05:41:38Z","timestamp":1775281298000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/477075-association-between-liver-dysfunction-markers-and-mortality-in-heart-failure-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":34,"URL":"https:\/\/doi.org\/10.7759\/cureus.106412","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,3]]}}}